---
$id: https://graph.org.ai/products/commodity/51361931
$type: Product
source: UNSPSC
code: "51361931"
title: "Brallobarbital calcium"
class: "51361900"
classTitle: "Hypnotic barbiturates"
family: "51360000"
familyTitle: "Hypnotics"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Brallobarbital calcium

**UNSPSC Code**: 51361931
**Class**: [Hypnotic barbiturates](Hypnotic barbiturates.mdx)
**Family**: [Hypnotics](../Hypnotics.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a barbiturate 2C10H10BrN2O3.Ca, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier L214YQB674, chemically known as 2,4,6(1h,3h,5h)-pyrimidinetrione, 5-(2-bromo-2-propenyl)-5-(2-propenyl)-, calcium salt (2:1), but more generally known as brallobarbital calcium, which bears US NIH Compound Identifier 71301214. European Medicines Agency schedules Brallobarbital calcium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00865MIG. Most nations, for tariff and trade purposes, schedule brallobarbital calcium under HS 29335400 and SITC kg. As of Q4 2014, BRALLOBARBITAL CALCIUM remains US FDA's Preferred Term for this commodity. SMILES: C=CCC1(C(=O)NC(=O)[N-]C1=O)CC(=C)BR.C=CCC1(C(=O)NC(=O)[N-]C1=O)CC(=C)BR.[CA+2].

